Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma

19Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Dopamine is a catecholamine that acts both as a neurotransmitter and as a hormone, exerting its functions via dopamine (DA) receptors that are present in a broad variety of organs and cells throughout the body. In the circulation, DA is primarily stored in and transported by blood platelets. Recently, the important contribution of DA in the regulation of angiogenesis has been recognized. In vitro and in vivo studies have shown that DA inhibits angiogenesis through activation of the DA receptor type 2. Overproduction of catecholamines is the biochemical hallmark of pheochromocytoma (PCC) and paraganglioma (PGL). The increased production of DA has been shown to be an independent predictor ofmalignancy in these tumors. The precise relationship underlying the association between DA production and PCC and PGL behavior needs further clarification. Here in, we reviewthe biochemical and physiologic aspects of DA with a focus on its relations with VEGF and hypoxia inducible factor related angiogenesis pathways, with special emphasis on DA producing PCC and PGL.

Cite

CITATION STYLE

APA

Osinga, T. E., Links, T. P., Dullaart, R. P. F., Pacak, K., Van Der Horst-Schrivers, A. N. A., Kerstens, M. N., & Kema, I. P. (2017, June 1). Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma. FASEB Journal. FASEB. https://doi.org/10.1096/fj.201601131R

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free